Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study.

近日，在科学研究的前沿领域，中国药科大学药学院的科研团队做出了重磅成果。这一突破的研究成果以“Antiviral signaling of a type III CRISPR-associated deaminase”为题，成功发表于国际顶尖学术期刊《Science》。这个研究不仅在学术界引起广泛关注，更为解决人类面临的健康难题提供了全新的视角。 文章背景与研究团队 适逢12月13日，中国药科大学 ...

无论是人类还是微生物，在生存过程中都会面临病毒（或噬菌体）的威胁。你知道吗？细菌虽然比人类简单，却也有自己的“免疫系统”用来保护自己免受感染。北京时间12月13日，我校药学院药理系、重庆中国药科大学创新研究院、多靶标天然药物全国重点实验室肖易倍教授， ...

Interleukin enhancer binding factor 2 (ILF2), formerly called nuclear factor 45 (NF45), is widely expressed in normal human tissues. ILF2 often binds to interleukin enhancer binding factor 3 (ILF3) ...

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies ...

Findings from a Phase 1 dose escalation trial of ASTX030, an investigational combination of azacitidine and cedazuridine, were shared with attendees during an oral presentation. In addition ...